These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 15220253)

  • 41. Circulating adiponectin levels are reduced in nonobese but insulin-resistant first-degree relatives of type 2 diabetic patients.
    Pellmé F; Smith U; Funahashi T; Matsuzawa Y; Brekke H; Wiklund O; Taskinen MR; Jansson PA
    Diabetes; 2003 May; 52(5):1182-6. PubMed ID: 12716750
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Decreased plasma adiponectin concentrations in women with low-grade C-reactive protein elevation.
    Matsubara M; Namioka K; Katayose S
    Eur J Endocrinol; 2003 Jun; 148(6):657-62. PubMed ID: 12773138
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Decreased high-molecular-weight adiponectin in gestational diabetes: implications for the pathophysiology of Type 2 diabetes.
    Retnakaran R; Connelly PW; Maguire G; Sermer M; Zinman B; Hanley AJ
    Diabet Med; 2007 Mar; 24(3):245-52. PubMed ID: 17305786
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Heterogeneity of cardiovascular risk factors profile in non-diabetic women 2-24 months post gestational diabetes mellitus.
    Sokup A; Ruszkowska-Ciastek B; Walentowicz-Sadłecka M
    Gynecol Endocrinol; 2014 May; 30(5):350-4. PubMed ID: 24734889
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Circulating concentrations of adiponectin and tumor necrosis factor-alpha in gestational diabetes mellitus.
    Altinova AE; Toruner F; Bozkurt N; Bukan N; Karakoc A; Yetkin I; Ayvaz G; Cakir N; Arslan M
    Gynecol Endocrinol; 2007 Mar; 23(3):161-5. PubMed ID: 17454170
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome.
    Spranger J; Möhlig M; Wegewitz U; Ristow M; Pfeiffer AF; Schill T; Schlösser HW; Brabant G; Schöfl C
    Clin Endocrinol (Oxf); 2004 Dec; 61(6):738-46. PubMed ID: 15579189
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasma adiponectin and insulin resistance in Korean type 2 diabetes mellitus.
    Kim MJ; Yoo KH; Park HS; Chung SM; Jin CJ; Lee Y; Shin YG; Chung CH
    Yonsei Med J; 2005 Feb; 46(1):42-50. PubMed ID: 15744804
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Early impairment of beta-cell function and insulin sensitivity characterizes normotolerant Caucasian women with previous gestational diabetes.
    Lencioni C; Volpe L; Miccoli R; Cuccuru I; Chatzianagnostou K; Ghio A; Benzi L; Bonadonna RC; Del Prato S; Di Cianni G
    Nutr Metab Cardiovasc Dis; 2006 Oct; 16(7):485-93. PubMed ID: 17015186
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of pioglitazone on circulating adipocytokine levels and insulin sensitivity in type 2 diabetic patients.
    Miyazaki Y; Mahankali A; Wajcberg E; Bajaj M; Mandarino LJ; DeFronzo RA
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4312-9. PubMed ID: 15356026
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Roux-en-Y gastric bypass decreases pro-inflammatory and thrombotic biomarkers in individuals with extreme obesity.
    Netto BD; Bettini SC; Clemente AP; Ferreira JP; Boritza K; Souza Sde F; Von der Heyde ME; Earthman CP; Dâmaso AR
    Obes Surg; 2015 Jun; 25(6):1010-8. PubMed ID: 25403776
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gestational diabetes mellitus is associated with increased C-reactive protein concentrations in the third but not second trimester.
    Leipold H; Worda C; Gruber CJ; Prikoszovich T; Wagner O; Kautzky-Willer A
    Eur J Clin Invest; 2005 Dec; 35(12):752-7. PubMed ID: 16313251
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Longitudinal Changes of High Molecular Weight Adiponectin are Associated with Postpartum Development of Type 2 Diabetes Mellitus in Patients with Gestational Diabetes Mellitus.
    Lee DH; Lim JA; Kim JH; Kwak SH; Choi SH; Jang HC
    Endocrinol Metab (Seoul); 2021 Feb; 36(1):114-122. PubMed ID: 33677933
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Elevated plasma SPARC levels are associated with insulin resistance, dyslipidemia, and inflammation in gestational diabetes mellitus.
    Xu L; Ping F; Yin J; Xiao X; Xiang H; Ballantyne CM; Wu H; Li M
    PLoS One; 2013; 8(12):e81615. PubMed ID: 24349098
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increased plasma leptin in gestational diabetes.
    Kautzky-Willer A; Pacini G; Tura A; Bieglmayer C; Schneider B; Ludvik B; Prager R; Waldhäusl W
    Diabetologia; 2001 Feb; 44(2):164-72. PubMed ID: 11270672
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pronounced insulin resistance and inadequate beta-cell secretion characterize lean gestational diabetes during and after pregnancy.
    Kautzky-Willer A; Prager R; Waldhausl W; Pacini G; Thomaseth K; Wagner OF; Ulm M; Streli C; Ludvik B
    Diabetes Care; 1997 Nov; 20(11):1717-23. PubMed ID: 9353615
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dietary factors associated with subclinical inflammation among girls.
    Del Mar Bibiloni M; Maffeis C; Llompart I; Pons A; Tur JA
    Eur J Clin Nutr; 2013 Dec; 67(12):1264-70. PubMed ID: 24149444
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Arterial stiffness, inflammatory and pro-atherogenic markers in gestational diabetes mellitus.
    Salmi AA; Zaki NM; Zakaria R; Nor Aliza AG; Rasool AH
    Vasa; 2012 Mar; 41(2):96-104. PubMed ID: 22403127
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The role of multicomponent therapy in the metabolic syndrome, inflammation and cardiovascular risk in obese adolescents.
    Masquio DC; de Piano A; Campos RM; Sanches PL; Carnier J; Corgosinho FC; Netto BD; Carvalho-Ferreira JP; Oyama LM; Nascimento CM; de Mello MT; Tufik S; Dâmaso AR
    Br J Nutr; 2015 Jun; 113(12):1920-30. PubMed ID: 25907896
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impaired glucose tolerance of pregnancy is a heterogeneous metabolic disorder as defined by the glycemic response to the oral glucose tolerance test.
    Retnakaran R; Zinman B; Connelly PW; Sermer M; Hanley AJ
    Diabetes Care; 2006 Jan; 29(1):57-62. PubMed ID: 16373896
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impaired circulating glucagon-like peptide-1 response to oral glucose in women with previous gestational diabetes.
    Forbes S; Moonan M; Robinson S; Anyaoku V; Patterson M; Murphy KG; Ghatei MA; Bloom SR; Johnston DG
    Clin Endocrinol (Oxf); 2005 Jan; 62(1):51-5. PubMed ID: 15638870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.